Denials & Appeals

CO-197: what a prior authorisation denial really costs

Most denials are recoverable. CO-197 frequently is not — and in many contracts you cannot bill the patient either. That makes it the most expensive denial category there is.

[CLIENT INPUT — denials lead], [CLIENT INPUT — CPB or CPC] Published 21 July 2026 · Updated 21 July 2026

Most denial codes describe a problem you can fix. CO-197 describes a decision you failed to obtain before you acted, and payers treat that differently.

Why it is worse than other denials

Three things make CO-197 the most expensive category on the remittance.

It is often unappealable. Some payers allow retroactive authorisation in defined circumstances — an emergency, a retroactive eligibility determination, a documented payer error. Most do not, and the appeal is decided on whether an exception applies rather than on the clinical merits.

It is often unbillable to the patient. Many participating provider agreements bar balance billing where the loss resulted from the practice's failure to obtain authorisation. The service was delivered, the cost was incurred, and there is no one to bill.

It arrives late. The denial lands weeks after the encounter, which means by the time you know the process failed, more encounters have already been processed the same way.

Where the process actually breaks

In our experience the failure is rarely someone forgetting. It is one of four structural gaps.

  • The requirement was not known. Authorisation requirements vary by payer, by plan within a payer, and by CPT code — and they change without notice. A requirement determined last quarter may not be current.
  • The authorisation was obtained but not attached. The number sits in a fax confirmation or an inbox and never reaches the claim. The service was authorised; the claim still denies.
  • The authorised units ran out. Common in therapy, behavioural health and wound care, where a course of treatment continues past the approved count. The first sessions pay and the last ones do not.
  • The authorisation expired. Approvals carry validity windows. A procedure rescheduled past that window is unauthorised even though an approval exists.

What it costs in practice

Take a procedure with a $900 allowed amount. A single CO-197 denial that cannot be appealed or balance billed is a straight $900 loss, plus the staff time already spent on scheduling, delivery, billing and the denial itself.

Compare that with a CO-16 on the same claim: a corrected claim goes back, the claim pays, and the cost is fifteen minutes.

That asymmetry is why authorisation deserves a dedicated process rather than a slot in the front desk's day.

What a working process looks like

  1. Determine the requirement at scheduling, per payer, per plan and per CPT code — not from memory.
  2. Submit with the clinical documentation attached. Requests submitted without supporting notes get pended, and pended requests become expired requests.
  3. Follow up on a fixed cadence. Payers have published turnaround standards. Track against them and escalate when they are exceeded rather than waiting.
  4. Capture the number against the claim so it survives the gap between approval and submission.
  5. Track remaining units and expiry dates and re-authorise before the last covered visit, not after.

The measurement that matters

If you want one number to watch, it is not your CO-197 count. It is the proportion of authorisation requests that are submitted before the date of service versus after it.

A practice submitting retroactive requests is not managing authorisation. It is apologising for it.

More like this

Find out what your practice is leaving on the table

Send us 90 days of claims data. We'll return a written analysis showing your denial rate, A/R ageing, and the specific revenue you're not collecting.

It's free, and you keep the report either way.